Economics of antenatal prophylaxis.
Cairns
J A
JA
Health Economics Research Unit, University of Aberdeen, UK.
D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004899:Erythroblastosis, Fetal / Q000191:economics / Q000517:prevention & control; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011295:Prenatal Care / Q000191:economics* / Q000379:methods; D019057:Quality-Adjusted Life Years; D012203:Rh Isoimmunization / Q000191:economics / Q000517:prevention & control*; D018029:Rho(D) Immune Globulin / Q000008:administration & dosage / Q000191:economics*; D016896:Treatment Outcome
D018029:Rho(D) Immune Globulin